Andover, MA, United States of America

Edimer Pharmaceuticals, Inc.


USPTO Granted Patents = 5

% Expired Patents = 20.0



Forward Citations = 2

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Pascal Schneider (5 out of 18 patents)

silverMedal Christine Kowalczyk-Quintas (2 out of 3 patents)

bronzeMedal Nathalie Dunkel (2 out of 2 patents)

4.  Stéphane Demotz (2 out of 2 patents)

5.  Neil Kirby (1 out of 2 patents)

6.  Anh Thu Dang (1 out of 1 patent)

7.  Christine Kowalczyk (1 out of 1 patent)

8.  Stephane Demotz (0 patent)


5 patents:

Edimer Pharmaceuticals, Inc. is a biotechnology company focused on developing novel therapies for rare, genetic disorders. The company's lead product candidate is EDI200, a potential treatment for X-linked hypohidrotic ectodermal dysplasia, a rare genetic disorder that impacts sweat gland function. Edimer is dedicated to improving the lives of patients with rare diseases through innovative research and development.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#33 in Andover, MA

#2,892 in Massachusetts

#51,570 in US

Andover, MA (US)
Andover, MA, United States of America
Forward Citations = 2

7 inventors:

Please report any incorrect information to [email protected]
Loading…